Changshan Pharmaceutical announced that the company recently received a notice that heparin sodium injection has obtained a drug registration certificate issued by the Bolivian Drug Administration. The dosage form is an injection, the specification is 5 ml, and it is valid until April 9, 2031. Heparin sodium injections are mainly used to prevent thrombosis or embolic diseases, diffuse intravascular coagulation, and also for anticoagulant treatment in operations such as hemodialysis. This certification has had a positive impact on the company's expansion into overseas markets. Currently, the company's overseas sales revenue for heparin formulation products accounts for a low proportion of total revenue, and drug sales are affected by factors such as overseas policies and exchange rate fluctuations, and there is uncertainty.

Changshan Pharmaceutical announced that the company recently received a notice that heparin sodium injection has obtained a drug registration certificate issued by the Bolivian Drug Administration. The dosage form is an injection, the specification is 5 ml, and it is valid until April 9, 2031. Heparin sodium injections are mainly used to prevent thrombosis or embolic diseases, diffuse intravascular coagulation, and also for anticoagulant treatment in operations such as hemodialysis. This certification has had a positive impact on the company's expansion into overseas markets. Currently, the company's overseas sales revenue for heparin formulation products accounts for a low proportion of total revenue, and drug sales are affected by factors such as overseas policies and exchange rate fluctuations, and there is uncertainty.